US 11939377
Affinity matured CD22-specific monoclonal antibody and uses thereof
granted A61KA61K2039/505A61K2039/804
Quick answer
US patent 11939377 (Affinity matured CD22-specific monoclonal antibody and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K2039/804, A61K2239/31, A61K2239/38